Glycyrrhiza glabra
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Glycyrrhiza glabra
- DrugBank Accession Number
- DB14312
- Background
Glycyrrhiza glabra is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Type
- Biotech
- Groups
- Approved, Experimental
- Synonyms
- Ae-licorice
- Cultivated Licorice Root
- Gan Cao Root
- Gancao (Glycyrrhiza Glabra)
- Glycyrrhiza
- Glycyrrhiza (Glycyrrhiza Glabra)
- Glycyrrhiza Glabra (Licorice) Rhizome/root
- Glycyrrhiza Glabra (Licorice) Rhizome/root Extract
- Glycyrrhiza Glabra (Licorice) Root
- Glycyrrhiza Glabra (Licorice) Root Extract
- Glycyrrhiza Glabra (Licorice) Root Powder
- Glycyrrhiza Glabra Extract
- Glycyrrhiza Glabra L Rhizome Extract
- Glycyrrhiza Glabra Processed Root
- Glycyrrhiza Glabra Rhizome
- Glycyrrhiza Glabra Root
- Glycyrrhiza Glabra Root Powder
- Glycyrrhiza Glabra Root With Rhizome
- Glycyrrhiza Glandulifera Root
- Glycyrrhiza Hirsuta Root
- Glycyrrhiza Pallida Root
- Glycyrrhiza Violacea Root
- Glycyrrhizae Radix Et Rhizoma (Glycyrrhiza Glabra)
- Glycyrrhizae Radix Et Rhizoma Praeparata Cum Melle (Glycyrrhiza Glabra)
- Guang Guo Gan Cao Root
- Licorice Allergenic Extract
- Licorice Extract
- Licorice Extract Powder
- Licorice Flavanoid Oil
- Licorice Rhizome/root Extract
- Liquiritiae Radix
- Liquorice Root (Glycyrrhiza Glabra)
- Prepared Liauorice Root (Glycyrrhiza Glabra)
- Russian Licorice Root
- Spanish Licorice Root
- Turkish Licorice Root
- Yashtimadhu Root
- Zhigancao (Glycyrrhiza Glabra)
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination for symptomatic treatment of Anxiety Combination Product in combination with: Ginger (DB10344), Pyridoxine (DB00165), Magnesium citrate (DB11110) ••• ••• ••••••• ••• •••••••• Symptomatic treatment of Mucus retention ••• ••• ••••••• •••••••• Used in combination for symptomatic treatment of Nausea Combination Product in combination with: Ginger (DB10344), Magnesium citrate (DB11110), Pyridoxine (DB00165) ••• ••• ••••••• ••• •••••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Gel Gel 12.5 mg/50g Cutaneous Shantou Youjia E-Commerce Co.,Ltd. 2024-02-01 2024-12-31 US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image ANKAFERD DERİ ÇÖZELTİSİ İÇEREN AMPUL Glycyrrhiza glabra (7 g/100mL) + Alpinia officinarum leaf (7 g/100mL) + Grape seed oil (8 g/100mL) + Thyme (5 g/100mL) + Urtica dioica pollen (6 g/100mL) Solution Topical İMMÜN GIDA İLAÇ KOZMETİK SAN. VE TİC. LTD. ŞTİ. 2017-11-07 Not applicable Turkey Bronchozone Cough Syrup Certified Glycyrrhiza glabra (0.012 mL / mL) + Ammonium carbonate (30 mg / mL) + Ammonium chloride (42 mg / mL) + Levomenthol (0.31 mg / mL) + Polygala senega root (0.015 mL / mL) Syrup Oral D.C. Labs Limited 1951-12-31 2003-07-11 Canada C Ottways Lax Tab Glycyrrhiza glabra (28 mg / tab) + Aloe vera leaf (132 mg / tab) + Capsicum (19 mg / tab) + Frangula purshiana bark (28 mg / tab) + Ginger (9 mg / tab) + Senna leaf (28 mg / tab) Tablet Oral C Ottway Herbalist 1950-12-31 1997-06-13 Canada Cennlacs Glycyrrhiza glabra (182 mg / g) + Senna leaf (726 mg / g) Powder Oral Westward Distributors 1983-12-31 1997-05-30 Canada Gluta Whitening Lazy Cream Glycyrrhiza glabra (7.5 g/30g) + Ascorbic acid (3 g/30g) + Glutathione (6 g/30g) + Nicotinamide (3 g/30g) + Pearl (hyriopsis cumingii) (1.5 g/30g) Cream Cutaneous Shantou Youjia E-Commerce Co., Ltd. 2024-02-01 2024-12-31 US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Maxclinic Cirmage Lifting Glycyrrhiza glabra (0.01 g/23g) + Adenosine (0.009 g/23g) Stick Topical N&b lab.co.ltd 2016-11-01 2018-12-01 US Medi SM 24K Gold Hydrogel Peptide Mask Pack Glycyrrhiza glabra (0.01 g/100g) + Adenosine (0.01 g/100g) + Butylene glycol (0.01 g/100g) + Chlorphenesin (0.01 g/100g) + Chondrus crispus (0.02 g/100g) + Glycerin (0.05 g/100g) + Gold (0.01 g/100g) + Nicotinamide (0.02 g/100g) + Polysorbate 20 (0.01 g/100g) + Polysorbate 60 (0.02 g/100g) + Potassium chloride (0.02 g/100g) + Propolis wax (0.01 g/100g) + Titanium dioxide (0.01 g/100g) + Xanthan gum (0.01 g/100g) Emulsion Topical Mbg Inc (Korea Institute of Science Development) 2017-11-07 2018-11-07 US
Categories
- Drug Categories
- Angiosperms
- Biological Products
- Cell-mediated Immunity
- Complex Mixtures
- Embryophyta
- Eukaryota
- Fabaceae
- Increased Histamine Release
- Non-Standardized Food Allergenic Extract
- Non-Standardized Plant Allergenic Extract
- Pharmaceutical Preparations
- Plant Preparations
- Streptophyta
- Tracheophyta
- Viridiplantae
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2788Z9758H
- CAS number
- 84775-66-6
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Prevention Chronic Periodontitis (Disorder) 1 2, 3 Completed Prevention Antimicrobial Effect / Caries / High Caries Risk Patients / Side Effects 1 1, 2 Completed Treatment Pancreatic Cancer 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Topical Syrup Oral Powder Oral Gel Cutaneous 12.5 mg/50g Cream Cutaneous Spray Cutaneous Stick Topical Emulsion Topical Lozenge Oral 60 mg Powder, for solution Oral Tablet Oral Suspension Pill Tablet, film coated Solution Syrup Tablet - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 05, 2018 17:13 / Updated at October 02, 2021 21:29